Clement Ma is a senior biotechnology commercialization and regulatory strategist with over two decades of experience translating complex diagnostic innovations into globally deployed healthcare products. As Chief Commercial & Regulatory Officer of GenTraceDx, he plays a critical role in operationalizing the company’s “Living Diagnostic” platform, ensuring that cutting-edge genomic technologies are not only scientifically advanced, but fully compliant, scalable, and commercially viable across international markets.

Global Regulatory & Market Access Leadership
Clement is widely recognized for his deep expertise in navigating the full spectrum of diagnostic regulatory pathways, including U.S. FDA (510(k), PMA, and LDT frameworks), Health Canada Medical Device Licensing, and reimbursement systems such as Medicare and Medicaid. His work has enabled the successful entry of numerous complex diagnostic products into highly regulated markets, bridging the gap between innovation and real-world clinical adoption.

He brings a rare ability to align regulatory strategy with commercialization objectives, accelerating time-to-market while maintaining rigorous compliance standards required for large-scale healthcare deployment.

End-to-End Commercial Execution at Scale
Over his 20+ year tenure with Genetrack Biolabs, Mr. Ma has led and executed multiple multinational diagnostic programs from concept through to retail distribution. His leadership spans:

• Acquisition and structuring of international LDT partnerships
• GMP manufacturing strategy and scale-up
• Product substantiation and validation
• Global logistics and distribution frameworks
• Retail and direct-to-consumer deployment

Technical & Digital Infrastructure Expertise
In addition to his regulatory and commercial leadership, Mr. Ma brings strong technical capabilities in full-stack software development and digital health infrastructure. He has contributed to the design and deployment of integrated diagnostic platforms that support secure data flow, regulatory compliance, and seamless user experience across physician and patient interfaces.

This combination of regulatory, operational, and technical expertise uniquely positions him to support the scalable deployment of GenTraceDx’s AI-driven precision oncology platform.

Strategic Role in GenTraceDx
At GenTraceDx, Mr. Ma is responsible for ensuring that the platform’s innovations are translated into globally deployable products, meeting the highest standards of regulatory compliance, manufacturability, and market readiness. His leadership ensures that GenTraceDx is not only scientifically transformative, but also positioned for rapid adoption across healthcare systems worldwide.